Share

    


Home / Search Results

Search Results

You searched for:

If you are looking for legislative action, look no further than your state's legislatures. Most—if not all—states have had issues relating to oncology care and healthcare in general come up during their 2023 sessions.
State legislation across the U.S. is tackling health insurance coverage for comprehensive biomarker testing. Learn more about what's going on where you live and across the nation.
Teri Bedard, RT(R)(T), CPC, shares her highlights of the calendar year 2023 HOPPS proposed rule and its potential impact on oncology/hematology.
Teri Bedard, RT(R)(T), CPC, shares her highlights of the calendar year 2023 MPFS proposed rule and its potential impact on oncology/hematology.
ACCC Director Cancer Care Delivery and Health Policy Matt Devino, MPH, lays out the four key differences between the OCM and EOM that interested applicants need to consider.
Advocating on behalf of their patients and programs, ACCC members from 14 states participated in Virtual Hill Day, speaking with Congress and their staff on key legislation asks regarding access to care, telehealth, prior authorizations, and more.
ACCC Board Member Wendi Waugh tells ACCCBuzz about her experience speaking at and attending the in-person Oncology Reimbursement Meetings this spring, covering topics from financial advocacy in oncology to formulary management and networking with colleagues to address workforce concerns at your cancer center.
ACCC is supporting the Improving Seniors’ Timely Access to Care Act of 2021, which would require Medicare Advantage plans to standardize and streamline prior authorization processes and increase the transparency of their requirements to prevent unnecessary denials and delays in patient care.
Jeanie Troy, a financial navigator at Lake Region Healthcare in the Cancer Care and Research Center, discusses how to help uninsured patients access their anti-cancer treatment if they are not eligible for Medicare or Medicaid.
If enacted, patients with cancer across the country will benefit from increased access and new fiscal protections, including universal paid family leave.
As we approach the end of 2021, ACCCBuzz is recognizing the individuals who have been featured in our Financial Advocate Spotlights and the incredible stories they have shared with us.
On June 1, 2021, the Governor of Louisiana signed legislation that banned “white bagging” in the state, ensuring that health insurers cannot refuse to pay for approved physician-administered drugs and related services to covered patients. It is the first such law in the United States.
In my new role at ACCC as senior director, cancer care delivery and health policy, I am excited to take over writing this bimonthly column and communicating to our multidisciplinary membership about pertinent workforce, reimbursement, and cancer care delivery issues.
On Aug. 4, the Centers for Medicare & Medicaid Services (CMS) released its 2021 Hospital Outpatient Prospective Payment System (OPPS) and Medicare Physician Fee Schedule (PFS) proposed rules.
At the end of last month, the Centers for Medicare & Medicaid Services (CMS) released the much-anticipated calendar year (CY) 2020 Medicare Payment rules. Touted by CMS as an effort to “empower patients with price transparency and increase competition to lower costs for Medicare beneficiaries,” the proposed Outpatient Prospective Payment System (OPPS) rule for 2020 introduces new price transparency …
Each year, in conjunction with the ACCC Annual Meeting and Cancer Center Business Summit, ACCC members come to Washington, D.C., for our Capitol Hill Day. Across the board, these members tell us how much they’ve enjoyed this unique opportunity to meet in small groups, or even one-on-one, with their legislators and congressional staffers to talk about challenges—and successes—at their cancer programs …
On July 25, 2018, the Centers for Medicare & Medicaid Services (CMS) released the CY 2019 Outpatient Prospective Payment System (OPPS) proposed rule, and we are seeing several efforts to continue the push towards “site neutral” payments in off-campus provider-based departments (PBDs). This rule was issued weeks after the CY 2019 Physician Fee Schedule (PFS) proposed rule, and the atypical lag time …
It’s been nearly one month since President Trump announced the administration’s plan to tackle rising drug costs through a four-pronged policy approach outlined in American Patients First: The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. Despite the blueprint’s lack of policy detail, two specific proposals appear to be bubbling to the top of the White House’s …